Skip to main content
. 2017 May 18;12(5):e0177352. doi: 10.1371/journal.pone.0177352

Fig 2. Predicted kinetic profiles obtained by simulations from the viral and ALT kinetic models.

Fig 2

(panel A) Different viral kinetics according to HCV-genotypes, NS5A-inhibitors and interferon administration, (panel B) Different ALT kinetics according to NS5A-inhibitors and interferon administration. ALT, alanine transaminase; IFN, interferon.